Who
Edward J. Benz Jr.
Director
Company insider
Files Form 4 as: Director, Candel Therapeutics; Director, Deciphera Pharmaceuticals; Director, Renovacor; Director, Xenetic Biosciences.
In numbers
- Trades disclosed
- 32
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 20 Dec 2016
- Last trade
- 23 Jun 2026
- Last filed
- 24 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Jun 2026filed 24 Jun 2026 | CADL Candel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —32,000 at $0.00 | filing |
| 23 Jun 2026filed 24 Jun 2026 | CADL Candel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —32,000 at $0.00 | filing |
| 17 Jun 2025filed 18 Jun 2025 | CADL Candel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,240 at $0.00 | filing |
| 26 Jun 2024filed 27 Jun 2024 | CADL Candel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,240 at $0.00 | filing |
| 11 Jun 2024filed 11 Jun 2024 | Deciphera Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —35,233 | filing |
| 11 Jun 2024filed 11 Jun 2024 | Deciphera Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —7,181 | filing |
| 11 Jun 2024filed 11 Jun 2024 | Deciphera Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —12,000 | filing |
| 11 Jun 2024filed 11 Jun 2024 | Deciphera Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —18,500 | filing |
| 11 Jun 2024filed 11 Jun 2024 | Deciphera Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —30,000 | filing |
| 28 Jun 2023filed 29 Jun 2023 | CADL Candel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,240 at $0.00 | filing |
| 21 Jun 2023filed 23 Jun 2023 | Deciphera Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 1 Dec 2022filed 5 Dec 2022 | Renovacoroption or derivative | SEC FORM 4 Code D | —9,060 at $0.00 | filing |
| 1 Dec 2022filed 5 Dec 2022 | Renovacoroption or derivative | SEC FORM 4 Code D | —24,000 at $0.00 | filing |
| 1 Dec 2022filed 5 Dec 2022 | Renovacoroption or derivative | SEC FORM 4 Code D | —12,000 at $0.00 | filing |
| 1 Dec 2022filed 5 Dec 2022 | Renovacor | SEC FORM 4 Code A | —3,586 | filing |
| 1 Dec 2022filed 5 Dec 2022 | Renovacor | SEC FORM 4 Code D | —3,586 | filing |
| 13 Oct 2022filed 17 Oct 2022 | CADL Candel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,240 at $0.00 | filing |
| 23 Jun 2022filed 24 Jun 2022 | Deciphera Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —18,500 at $0.00 | filing |
| 25 May 2022filed 27 May 2022 | Renovacoroption or derivative | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 3 Sep 2021filed 8 Sep 2021 | Renovacoroption or derivative | SEC FORM 4 Code A | —24,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.